93PDAfatinib (A) vs gefitinib (G) in patients with EGFR...

Annals of Oncology 2017 / 04 Vol. 28; Iss. suppl_2

93PDAfatinib (A) vs gefitinib (G) in patients with EGFR mutation-positive (EGFRm+) NSCLC: Updated OS data from the phase IIb trial LUX-Lung 7 (LL7)

Corral, J., Park, K., Yang, J.C-H., Mok, T., Tan, E-H., O'Byrne, K., Hirsh, V., Boyer, M., Fan, J., Zhang, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx091.013
Date:
April, 2017
File:
PDF, 50 KB
english, 2017
Conversion to is in progress
Conversion to is failed